多间室创伤导致肠道微生物组性别特异性改变
该研究为动物实验,将9至11周龄雄性及动情前期雌性Sprague-Dawley大鼠(每组n=8)分为多间室创伤组(PT:肺挫伤、失血性休克、盲肠切除、双股骨假骨折)、PT加每日2小时慢性束缚应激组(PT/CS)及naive对照组,于第0天和第2天用高通量16S rRNA测序检测粪便微生物组,并评估肠道通透性(血浆occludin、脂多糖结合蛋白)及回肠和结肠组织学损伤评分。结果:基线时雌性α多样性(Chao1、Shannon指数)显著高于雄性(p<0.05),伤后第2天PT和PT/CS组此差异消失;PT后β多样性与雄性显著不同(p=0.01)。第2天PT/CS雌性微生物组成以双歧杆菌为主,PT雄性罗斯氏菌升高(p<0.01);PT/CS雄性回肠损伤评分显著高于雌性(p=0.0002);PT雄性血浆occludin高于雌性(p=0.004),PT/CS雄性血浆脂多糖结合蛋白升高(p=0.03)。结论认为多间室创伤诱导微生物组多样性和菌群改变,这些特征因宿主性别而异,提示性别是可能影响严重创伤和重症结局的重要生物学变量。
要点
- 9至11周龄Sprague-Dawley大鼠(每组n=8)接受多间室创伤(PT:肺挫伤、失血性休克、盲肠切除、双股骨假骨折)后,PT/CS雄性回肠损伤评分显著高于雌性(p=0.0002)。
- 基线时雌性α多样性(Chao1、Shannon指数)显著高于雄性(p<0.05),伤后第2天PT和PT/CS组此差异消失。
- PT后β多样性与雄性显著不同(p=0.01);第2天PT/CS雌性微生物组成以双歧杆菌为主,PT雄性罗斯氏菌升高(p<0.01)。
- PT雄性血浆occludin高于雌性(p=0.004),PT/CS雄性血浆脂多糖结合蛋白升高(p=0.03)。
- 作者认为性别是可能影响严重创伤和重症结局的重要生物学变量。
适用人群与场景
- 9至11周龄雄性及动情前期雌性Sprague-Dawley大鼠,每组n=8。
- 实验分组:多间室创伤组(PT:肺挫伤、失血性休克、盲肠切除、双股骨假骨折)、PT加每日2小时慢性束缚应激组(PT/CS)、naive对照组。
诊断标准与关键阈值
- α多样性采用Chao1(不同独特物种数)和Shannon(物种丰富度与均匀度)指数评估;β多样性采用主坐标分析评估。
- 肠道通透性通过血浆occludin和脂多糖结合蛋白评估。
- 回肠和结肠组织学损伤由盲法病理学家评分。
- 统计学显著性定义为雄性对比雌性p<0.05。
处置流程与药物剂量
- 粪便微生物组于第0天和第2天采用高通量16S rRNA测序及QIIME生物信息学分析检测。
研究设计与关键结果
- 动物实验:雄性及动情前期雌性Sprague-Dawley大鼠(每组n=8),分为PT组、PT/CS组或naive对照组,第0天和第2天检测粪便微生物组。
- 基线时雌性α多样性(Chao1、Shannon指数)显著高于雄性(p<0.05),伤后第2天PT和PT/CS组此差异消失。
- PT后β多样性与雄性显著不同(p=0.01)。
- 第2天PT/CS雌性微生物组成以双歧杆菌为主,PT雄性罗斯氏菌升高(p<0.01)。
- PT/CS雄性回肠损伤评分显著高于雌性(p=0.0002)。
- PT雄性血浆occludin高于雌性(p=0.004);PT/CS雄性血浆脂多糖结合蛋白升高(p=0.03)。
证据类型、等级与局限
- 证据类型:动物实验(大鼠)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为性别是可能影响严重创伤和重症结局的重要生物学变量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous preclinical studies have demonstrated an altered gut microbiome after traumatic injury; however, the impact of sex on dysbiosis remains unknown. We hypothesized that the "pathobiome" phenotype induced by multicompartmental injuries and chronic stress is host sex specific with unique microbiome signatures.
METHODS: Male and proestrus female Sprague-Dawley rats (n = 8/group) aged 9 weeks to 11 weeks were subjected to either multicompartmental injury (PT) (lung contusion, hemorrhagic shock, cecectomy, bifemoral pseudofractures), PT plus 2 hours daily chronic restraint stress (PT/CS) or naive controls. Fecal microbiome was measured on Days 0 and 2 using high-throughput 16S rRNA sequencing and Quantitative Insights Into Microbial Ecology bioinformatics analyses. Microbial alpha-diversity was assessed using Chao1 (number of different unique species) and Shannon (species richness and evenness) indices. Beta-diversity was assessed using principle coordinate analysis. Intestinal permeability was evaluated by plasma occludin and lipopolysaccharide binding protein. Histologic evaluation of ileum and colon tissues was scored for injury by a blinded pathologist. Analyses were performed in GraphPad and R, with significance defined as p < 0.05 between males versus females.
RESULTS: At baseline, females had significantly elevated alpha-diversity (Chao1, Shannon indices) compared with males ( p < 0.05) which was no longer present 2 days postinjury in PT and PT/CS. Beta-diversity also differed significantly between males and females after PT ( p = 0.01). At Day 2, the microbial composition in PT/CS females was dominated by Bifidobacterium , whereas PT males demonstrated elevated levels of Roseburia ( p < 0.01). The PT/CS males had significantly elevated ileum injury scores compared with females ( p = 0.0002). Plasma occludin was higher in PT males compared with females ( p = 0.004); plasma lipopolysaccharide binding protein was elevated in PT/CS males ( p = 0.03).
CONCLUSION: Multicompartmental trauma induces significant alterations in microbiome diversity and taxa, but these signatures differ by host sex. These findings suggest that sex is an important biological variable that may influence outcomes after severe trauma and critical illness.
参考来源
- Munley JA, Kelly LS, Park G, et al. Multicompartmental traumatic injury induces sex-specific alterations in the gut microbiome. J Trauma Acute Care Surg. 2023. PMID: 36872509. doi:10.1097/TA.0000000000003939
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。